G551D Observational Study- Expanded to Additional Genotypes and Extended for Long Therm Follow up (GOAL-e2)
NCT01521338 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2021-06-30
Summary
The goal of this research study is to collect blood and urine samples from people who have either the R117H type of CF or the non-G551D gating type of CF to be kept for future research.We will also use some of the collected blood to measure the number of neutrophils.
Conditions
Sponsors & Collaborators
-
Steven M Rowe
lead OTHER
Principal Investigators
-
Steven M Rowe, MD · University of Alabama at Birmingham
Eligibility
- Min Age
- 6 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-01-31
- Primary Completion
- 2021-06-30
- Completion
- 2021-06-30
Countries
- United States
Study Locations
More Related Trials
-
A Phase 2 IV Gallium Study for Patients With Cystic Fibrosis (IGNITE Study)
NCT02354859 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Determine the Variability of a 6-Minute Walk Test in Cystic Fibrosis Subjects With Advanced Lung Disease
NCT00311506 ·Status: COMPLETED
-
Real-Time Assessment of Lung Structure and Function in Children and Young Adults With CF Using Electrical Impedance Tomography
NCT05455671 ·Status: COMPLETED
-
Diagnosis and Treatment of Patients With Cystic Fibrosis
NCT00001223 ·Status: TERMINATED
-
Cystic Fibrosis (CF) Leukocyte Genes as Biomarkers for Novel Therapies
NCT00727285 ·Status: COMPLETED
-
Longitudinal Analysis of Respiratory and Intestinal Microbiome in Cystic Fibrosis
NCT03335202 ·Status: UNKNOWN
-
Tracking CF Lung Disease Through the Early Years: Utility of the LCI
NCT03138772 ·Status: COMPLETED
-
Combating Diagnostic Wandering and Impasse for Cystic Fibrosis
NCT05654480 ·Status: UNKNOWN
-
Prospective Study of the Phenotypic Expression of Cystic Fibrosis (CF) Screened Positive Newborns With an Atypical Form of CF (DPAM)
NCT02869932 ·Status: COMPLETED ·Phase: NA
-
Biodistribution of Neutrophile Proteases in the Sputum of Patients Affected by Cystic Fibrosis
NCT00750932 ·Status: COMPLETED
-
Performance and Patient Acceptance of a Commercially Available Beverage as Compared to an Oral Glucose Solution for Oral Glucose Tolerance Tests in Cystic Fibrosis (CF) Patients Who Are Screened for CF-related Diabetes.
NCT05377502 ·Status: UNKNOWN
-
Observational Trial of the Longitudinal Effects of CFTR Modulator Drugs
NCT04353752 ·Status: COMPLETED
-
Early Intervention in Pulmonary Exacerbation in Cystic Fibrosis
NCT00850551 ·Status: COMPLETED ·Phase: NA
-
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
NCT06504589 ·Status: RECRUITING
-
Analysis T Cells Response for Identification of Aspergillus Bronchitis With Cystic Fibrosis Patients
NCT02550041 ·Status: TERMINATED ·Phase: NA
-
Serum Zn Status of Patients With Cystic Fibrosis at Diagnosis and One Year Later, Compared to a Healthy Control Group
NCT00221559 ·Status: COMPLETED
-
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
NCT02109822 ·Status: COMPLETED
-
6 Minute Walk Test in Cystic Fibrosis
NCT02538575 ·Status: COMPLETED ·Phase: NA
-
Cystic Fibrosis Blood Neutrophils
NCT04970225 ·Status: COMPLETED ·Phase: NA
-
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
NCT01851642 ·Status: RECRUITING
-
Asthma With Hypersecretion-associated Gene for Cystic Fibrosis
NCT02558127 ·Status: COMPLETED
-
Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis
NCT06747858 ·Status: RECRUITING ·Phase: PHASE2
-
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
NCT01858519 ·Status: COMPLETED
-
PATIENCE Trial: Prospective Algorithm for Treatment of NTM in Cystic Fibrosis
NCT02419989 ·Status: ENROLLING_BY_INVITATION
-
Detection of Unsuspected Small Airways Obstruction in Cystic Fibrosis
NCT03839992 ·Status: RECRUITING